Tuoxin Pharmaceutical: Shareholder Yiwosi Trading Co., Ltd. reduced its holdings by 0.23% of the company's shares

Tuoxin Pharmaceutical announced that the company's stock deviated by a cumulative 45.65% over two consecutive trading days on May 15 and 16, 2025, which constitutes an abnormal fluctuation. After verification, the company confirmed that there are no corrections or supplements needed for the information previously disclosed, and no undisclosed significant information has been found that may have a substantial impact on the company's stock trading price. The company's controlling shareholder and actual controller do not have any significant matters that should have been disclosed but were not. Shareholder Yiwosi Trading Co., Ltd. reduced its shareholding during the stock's abnormal fluctuation period through centralized bidding and block trading, accounting for 0.23% of the total share capital. The company's net profit for 2024 was -19.8849 million yuan, a decrease of 108.18% compared to 2023; the net profit for the first quarter of 2025 was -3.5647 million yuan, a decrease of 272.34% compared to the same period last year